Theravance Biopharma, Inc. - Ordinary Shares financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 11/08/2026 | Mar 2026Filed 07/05/2026 | Dec 2025Filed 23/03/2026 | Sep 2025Filed 23/03/2026 | Jun 2025Filed 11/08/2026 | Mar 2025Filed 07/05/2026 | Dec 2024Filed 23/03/2026 | Sep 2024Filed 23/03/2026 |
|---|---|---|---|---|---|---|---|---|
| $21 | $18 | $46 | $20 | $26 | $15 | $19 | $17 | |
| −$5.9 | −$4.9 | $61 | $3.6 | $55 | −$14 | −$16 | −$13 | |
| −$0.11 | −$0.10 | $1.15 | $0.07 | $1.08 | −$0.27 | −$0.31 | −$0.26 | |
| 52 | 51 | — | 52 | 51 | 50 | — | 49 |
Trend